Evidence map›Paper›PMID 29042182›Full record

ReviewHormones and behavior2018

Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder?

Amer Moosa, Henry Shu, Tewarit Sarachana, Valerie W Hu

Open access · greenAbstract readReview
In one paragraph

Review in Hormones and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 93 citations in OpenAlex.

  1. Effects ofNutrients · 2019
    Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Adsorption behavior of bisphenol A on bentonite-loess mixtures.Environmental science and pollution research international · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Amer MoosaDept. of Biochemistry and Molecular Medicine, The George Washington University School of Medicine and Health Sciences, 2300 Eye St., NW, Washington, DC 20037, United States. Electronic address: amoosa@gwu.edu.
Henry ShuDept. of Biochemistry and Molecular Medicine, The George Washington University School of Medicine and Health Sciences, 2300 Eye St., NW, Washington, DC 20037, United States. Electronic address: henry_shu@gwu.edu.
Tewarit SarachanaDepartment of Clinical Chemistry, Medical Technology Branch, Faculty of Allied Health Sciences, Chulalongkorn University, 154 Rama I Rd., Wangmai, Pathumwan, Bangkok 10330, Thailand. Electronic address: tewarit.sa@chula.ac.th.
Valerie W HuDept. of Biochemistry and Molecular Medicine, The George Washington University School of Medicine and Health Sciences, 2300 Eye St., NW, Washington, DC 20037, United States. Electronic address: valhu@gwu.edu.
George Washington University · USChulalongkorn University · TH

Funding

Are endocrine disrupting compounds environmental risk factors for autism?R21ES023061 · NIEHS · GEORGE WASHINGTON UNIVERSITY · PI HU, VALERIE W · 2014 to 2015
$436k
NIEHS NIH HHS R21 ES023061
6 · The paper itself

Abstract

Recent research on the etiology of autism spectrum disorder (ASD) has shifted in part from a singular focus on genetic causes to the involvement of environmental factors and their gene interactions. This shift in focus is a result of the rapidly increasing prevalence of ASD coupled with the incomplete penetrance of this disorder in monozygotic twins. One such area of environmentally focused research is the association of exposures to endocrine disrupting compounds (EDCs) with elevated risk for ASD. EDCs are exogenous chemicals that can alter endogenous hormone activity and homeostasis, thus potentially disrupting the action of sex and other natural hormones at all stages of human development. Inasmuch as sex hormones play a fundamental role in brain development and sexual differentiation, exposure to EDCs in utero during critical stages of development can have lasting neurological and other physiological influences on the developing fetus and, ultimately, the child as well as adult. This review will focus on the possible contributions of EDCs to autism risk and pathogenesis by first discussing the influence of endogenous sex hormones on the autistic phenotype, followed by a review of documented human exposures to EDCs and associations with behaviors relevant to ASD. Mechanistic links between EDC exposures and aberrant neurodevelopment and behaviors are then considered, with emphasis on EDC-induced transcriptional profiles derived from animal and cellular studies. Finally, this review will discuss possible mechanisms through which EDC exposure can lead to persistent changes in gene expression and phenotype, which may in turn contribute to transgenerational inheritance of ASD.

Indexed as

AnimalsAutism Spectrum DisorderChildEndocrine DisruptorsEnvironmental ExposureGene-Environment InteractionGene Expression Regulation, DevelopmentalHormonesHumansInheritance PatternsRisk FactorsEndocrine DisruptorsHormonesAutismEndocrine disrupting compoundsEpigeneticsGene expressionNeurodevelopmentSex hormones

Identifiers

PMID29042182
PMCPMC5913002
OpenAlexW2765521859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.